16-1218979-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021098.3(CACNA1H):​c.5897C>T​(p.Ala1966Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0216 in 1,550,154 control chromosomes in the GnomAD database, including 431 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 29 hom., cov: 31)
Exomes 𝑓: 0.022 ( 402 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.978

Publications

10 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0041008294).
BP6
Variant 16-1218979-C-T is Benign according to our data. Variant chr16-1218979-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 166781.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0153 (2328/152242) while in subpopulation SAS AF = 0.0271 (131/4834). AF 95% confidence interval is 0.0233. There are 29 homozygotes in GnomAd4. There are 1169 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 2328 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.5897C>T p.Ala1966Val missense_variant Exon 34 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.5897C>T p.Ala1966Val missense_variant Exon 34 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.5912C>T p.Ala1971Val missense_variant Exon 33 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000565831.7 linkc.5879C>T p.Ala1960Val missense_variant Exon 33 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000638323.1 linkc.5858C>T p.Ala1953Val missense_variant Exon 34 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000711438.1 linkc.5840C>T p.Ala1947Val missense_variant Exon 33 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.5897C>T p.Ala1966Val missense_variant Exon 34 of 36 ENSP00000518771.1
CACNA1HENST00000711483.1 linkc.5897C>T p.Ala1966Val missense_variant Exon 34 of 35 ENSP00000518772.1
CACNA1HENST00000621827.2 linkn.5897C>T non_coding_transcript_exon_variant Exon 34 of 37 6 ENSP00000518766.1
CACNA1HENST00000711442.1 linkn.*5341C>T non_coding_transcript_exon_variant Exon 32 of 34 ENSP00000518758.1
CACNA1HENST00000711449.1 linkn.*756C>T non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518761.1
CACNA1HENST00000711452.1 linkn.*564C>T non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518764.1
CACNA1HENST00000711486.1 linkn.5897C>T non_coding_transcript_exon_variant Exon 34 of 37 ENSP00000518775.1
CACNA1HENST00000711488.1 linkn.*1013C>T non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518777.1
CACNA1HENST00000711442.1 linkn.*5341C>T 3_prime_UTR_variant Exon 32 of 34 ENSP00000518758.1
CACNA1HENST00000711449.1 linkn.*756C>T 3_prime_UTR_variant Exon 34 of 35 ENSP00000518761.1
CACNA1HENST00000711452.1 linkn.*564C>T 3_prime_UTR_variant Exon 35 of 36 ENSP00000518764.1
CACNA1HENST00000711488.1 linkn.*1013C>T 3_prime_UTR_variant Exon 34 of 35 ENSP00000518777.1
CACNA1HENST00000711493.1 linkc.5906-24C>T intron_variant Intron 32 of 33 ENSP00000518778.1
CACNA1HENST00000711450.1 linkc.5903-24C>T intron_variant Intron 33 of 34 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.5888-24C>T intron_variant Intron 33 of 34 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000562079.6 linkc.5870-24C>T intron_variant Intron 32 of 33 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711485.1 linkc.5870-24C>T intron_variant Intron 32 of 34 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.5888-69C>T intron_variant Intron 33 of 35 ENSP00000518768.1
CACNA1HENST00000711456.1 linkc.5887+328C>T intron_variant Intron 33 of 33 ENSP00000518769.1
CACNA1HENST00000637236.3 linkn.*1840-24C>T intron_variant Intron 32 of 33 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*969-24C>T intron_variant Intron 33 of 34 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3739-24C>T intron_variant Intron 33 of 34 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711448.1 linkn.*862-24C>T intron_variant Intron 34 of 35 ENSP00000518760.1
CACNA1HENST00000711451.1 linkn.*1500-24C>T intron_variant Intron 34 of 35 ENSP00000518763.1
CACNA1HENST00000711453.1 linkn.*555-24C>T intron_variant Intron 34 of 35 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.5870-24C>T intron_variant Intron 32 of 34 ENSP00000518773.1
CACNA1HENST00000711487.1 linkn.5888-24C>T intron_variant Intron 33 of 35 ENSP00000518776.1

Frequencies

GnomAD3 genomes
AF:
0.0153
AC:
2327
AN:
152124
Hom.:
29
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00394
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0108
Gnomad ASJ
AF:
0.00720
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0269
Gnomad FIN
AF:
0.0211
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0234
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.0170
AC:
2628
AN:
154172
AF XY:
0.0176
show subpopulations
Gnomad AFR exome
AF:
0.00401
Gnomad AMR exome
AF:
0.00743
Gnomad ASJ exome
AF:
0.00768
Gnomad EAS exome
AF:
0.0000922
Gnomad FIN exome
AF:
0.0206
Gnomad NFE exome
AF:
0.0239
Gnomad OTH exome
AF:
0.0163
GnomAD4 exome
AF:
0.0223
AC:
31200
AN:
1397912
Hom.:
402
Cov.:
33
AF XY:
0.0223
AC XY:
15400
AN XY:
689506
show subpopulations
African (AFR)
AF:
0.00298
AC:
94
AN:
31594
American (AMR)
AF:
0.00801
AC:
286
AN:
35690
Ashkenazi Jewish (ASJ)
AF:
0.00870
AC:
219
AN:
25164
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35734
South Asian (SAS)
AF:
0.0235
AC:
1858
AN:
79228
European-Finnish (FIN)
AF:
0.0207
AC:
995
AN:
48054
Middle Eastern (MID)
AF:
0.0108
AC:
61
AN:
5636
European-Non Finnish (NFE)
AF:
0.0246
AC:
26557
AN:
1078830
Other (OTH)
AF:
0.0195
AC:
1129
AN:
57982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
1616
3231
4847
6462
8078
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1006
2012
3018
4024
5030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0153
AC:
2328
AN:
152242
Hom.:
29
Cov.:
31
AF XY:
0.0157
AC XY:
1169
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.00392
AC:
163
AN:
41540
American (AMR)
AF:
0.0108
AC:
165
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00720
AC:
25
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.0271
AC:
131
AN:
4834
European-Finnish (FIN)
AF:
0.0211
AC:
224
AN:
10622
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0234
AC:
1593
AN:
68000
Other (OTH)
AF:
0.0123
AC:
26
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
109
217
326
434
543
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0142
Hom.:
8
Bravo
AF:
0.0132
TwinsUK
AF:
0.0256
AC:
95
ALSPAC
AF:
0.0252
AC:
97
ESP6500AA
AF:
0.00475
AC:
16
ESP6500EA
AF:
0.0202
AC:
133
ExAC
AF:
0.0114
AC:
435
Asia WGS
AF:
0.00895
AC:
31
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Dec 20, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 14, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Jul 13, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Nov 04, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
15
DANN
Benign
0.79
DEOGEN2
Benign
0.082
T;.;.;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.39
N
LIST_S2
Benign
0.58
T;T;T;.
MetaRNN
Benign
0.0041
T;T;T;T
MetaSVM
Uncertain
-0.11
T
MutationAssessor
Benign
0.90
L;.;.;.
PhyloP100
0.98
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.050
N;.;N;N
REVEL
Benign
0.29
Sift
Benign
0.30
T;.;T;T
Sift4G
Benign
0.51
T;.;T;T
Polyphen
0.0010
B;.;B;B
Vest4
0.045
ClinPred
0.00072
T
GERP RS
3.5
La Branchor
0.40
Varity_R
0.029
gMVP
0.19
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.16
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72552054; hg19: chr16-1268979; API